Fresenius Kabi

Leader of R&D Digitalization & Advanced Analytics

Fresenius Kabi  •  $130k - $150k/yr  •  Melrose Park, IL (Onsite)  •  17 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

The Head of R&D Digitalization & Advanced Analytics leads the end‑to‑end digital transformation of Global R&D, shaping the strategy and execution of digital, data, and automation initiatives across all R&D centers. This role is responsible for mapping scientific and operational processes, identifying opportunities to digitalize workflows, and enabling the effective use of data to accelerate development timelines, enhance decision‑making, and increase productivity.
A key mandate of the position is to convert scientific and operational data into predictive insights that support advanced modeling, simulation, and virtual experimentation (such as virtual labs) to drive faster, more robust formulation and drug product development. The role serves as a strategic integrator between science, data, and technology, partnering closely with R&D functions, IT, external collaborators, and senior leadership to embed digital capabilities into everyday R&D execution.
Salary Range: $130,000-150,000
Position is eligible to participate in an annual bonus plan with a target of 14% of the base salary.
Final pay determinations will depend on various factors, including, but not limited to experience level, education, knowledge, skills, and abilities.
Our benefits and programs are comprehensive and thoughtfully crafted to ensure our colleagues live healthy lives and have support when it matters most. Benefits offered include a 401(k) plan with company contributions, paid vacation, holiday and personal days, employee assistance program, and health benefits to include medical, prescription drug, dental and vision coverage.

Responsibilities

R&D Digital Strategy & Roadmap

  • Develop and own the global R&D digitalization strategy aligned with R&D and BU Pharma objectives.
  • Map end to end R&D processes across all R&D centers (e.g., formulation, analytical, MS&T, feasibility, lifecycle) to identify automation and digitalization opportunities.
  • Prioritize initiatives based on scientific impact, speed, scalability, and return on investment.
  • Automation & Process Digitalization
  • Identify repetitive, manual, or data intensive R&D activities suitable for automation.
  • Drive implementation of automation solutions (e.g., data capture, workflow automation, integration of lab systems).
  • Establish global standards for digital tools and processes to ensure scalability and consistency across sites.

Advanced Analytics, Modeling & Virtual Development

  • Leverage R&D scientific data to build predictive models supporting formulation development, process optimization, and risk assessment.
  • Enable simulation based and data driven development approaches, including virtual labs and in silico experimentation, to reduce experimental cycles and accelerate decision making.
  • Partner with formulation, analytical, and MS&T experts to ensure models are scientifically sound and fit for purpose.

Data & Digital Enablement

  • Define R&D data architecture needs in collaboration with IT, ensuring accessibility, integrity, and regulatory compliance.
  • Promote reuse of scientific data across projects and lifecycle stages.
  • Embed digital tools into core R&D workflows rather than as standalone pilots.

Cross Functional Leadership & Change Management

  • Act as a change leader, driving adoption of digital tools and new ways of working across R&D sites.
  • Build strong partnerships with R&D leaders, IT, Quality, Regulatory, and external technology partners.
  • Develop digital and data capabilities within R&D through targeted upskilling and talent development.

Governance & Value Tracking

  • Establish clear governance for digital initiatives, including prioritization, milestones, and success metrics.
  • Track and communicate impact (e.g., cycle time reduction, cost avoidance, quality improvement, scientific insight generation).
  • Ensure digital investments deliver measurable business and scientific value.

Key Interfaces

Global R&D Leadership Team

Heads of Formulation, Analytical, MS&T, Feasibility, and Lifecycle Management

IT / Digital / Data Science teams

Quality and Regulatory

External technology and analytics partners

Additional Information

We offer an excellent salary and benefits package including medical, dental and vision coverage, as well as life insurance, disability, 401K with company contribution, and wellness program.

Please note that joining our team does not create a guaranteed or permanent employment arrangement. All employment is at‑will, meaning both the employee and Fresenius Kabi have the right to end the employment relationship at any time, in accordance with applicable federal and state laws.

Fresenius Kabi is an Equal Opportunity/Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, citizenship, immigration status, disabilities, or protected veteran status.

Fresenius Kabi

About Fresenius Kabi

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.

In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.

Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.

Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.

User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions

Imprint: www.fresenius-kabi.com/imprint

Industry
Chemicals & Materials
Company Size
10,000+ employees
Headquarters
Bad Homburg, DE
Year Founded
Unknown
Social Media